Immune Function in Patients with Rheumatoid Arthritis Treated with Etanercept
- 1 April 2002
- journal article
- clinical trial
- Published by Elsevier in Clinical Immunology
- Vol. 103 (1) , 13-21
- https://doi.org/10.1006/clim.2001.5183
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving MethotrexateNew England Journal of Medicine, 1999
- Deactivation of vascular endothelium by monoclonal anti–tumor necrosis factor α antibody in rheumatoid arthritisArthritis & Rheumatism, 1996
- The mortality of rheumatoid arthritisArthritis & Rheumatism, 1994
- Localization of Tumor Necrosis Factor α in Synovial Tissues and at the Cartilage–Pannus Junction in Patients With Rheumatoid ArthritisArthritis & Rheumatism, 1991
- The Role of the Neutrophil in Rheumatoid ArthritisPublished by Wolters Kluwer Health ,1991
- Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serumArthritis & Rheumatism, 1988
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- CAUSE OF DEATH IN RHEUMATOID ARTHRITISRheumatology, 1984
- Course and Prognosis in Rheumatoid ArthritisAnnals of the Rheumatic Diseases, 1964